Aprecia Pharmaceuticals
Curated by SignalDevelops & manufactures orodispersible formulations of highly prescribed high-dose medications using proprietary drug delivery systems.
Overview
Aprecia Pharmaceuticals develops and manufactures orodispersible tablets with a focus on high-dose medications using ZipDose Technology. ZipDose Technology utilizes its proprietary three-dimensional printing (3DP) platform. This process stitches together multiple layers of powdered medication using an aqueous fluid to produce a porous, water-soluble matrix that rapidly disintegrates with a sip of liquid. FDA has recently approved SPRITAM levetiracetam for oral use as a prescription adjunctive therapy in the treatment of partial onset seizures, myoclonic seizures and primary generalized tonic-clonic seizures in adults and children with epilepsy. SPRITAM utilizes its proprietary ZipDose Technology platform to produce a porous formulation that rapidly disintegrates with a sip of liquid. It plans to introduce multiple new products utilizing ZipDose Technology, focusing first on the central nervous system therapeutic area.
Key facts
- Founded
- 2003
- Headquarters
- Langhorne, United States
- Stage
- Sign up to view
- Industry
- Life Sciences Technology
Business model
- 5 products and services
- Sign up to view
Contact
- Primary office
- Sign up to view
Open roles
2 rolesManager of Regulatory Affairs
Mason, OH · On-site · Volunteer
Systems Software Engineer
Mason, OH · On-site · Volunteer